MetaCap

Compass Therapeutics (CMPX) News

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CMPX news summary

We found 7 recent headlines mentioning Compass Therapeutics (CMPX): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, CMPX is up 1.43% at $0.6882. The most recent story, "Compass Therapeutics, Inc. Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Compass Therapeutics headlines

Compare CMPX